BR112017003920A2 - sistema de fórmulas infantis para lactentes com teores adaptativos de oligossacarídeos de leite humano (hmos) - Google Patents

sistema de fórmulas infantis para lactentes com teores adaptativos de oligossacarídeos de leite humano (hmos)

Info

Publication number
BR112017003920A2
BR112017003920A2 BR112017003920A BR112017003920A BR112017003920A2 BR 112017003920 A2 BR112017003920 A2 BR 112017003920A2 BR 112017003920 A BR112017003920 A BR 112017003920A BR 112017003920 A BR112017003920 A BR 112017003920A BR 112017003920 A2 BR112017003920 A2 BR 112017003920A2
Authority
BR
Brazil
Prior art keywords
infants
hmos
human milk
milk oligosaccharides
infant formula
Prior art date
Application number
BR112017003920A
Other languages
English (en)
Inventor
Antonio De Castro Carlos
Destaillats Frédéric
Sprenger Norbert
Thakkar Sagar
Christopher Austin Sean
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=54238414&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112017003920(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112017003920A2 publication Critical patent/BR112017003920A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

esta invenção refere-se a um sistema de composições nutricionais adaptadas à idade, que compreende um teor adaptativo de oligossacarídeos de leite humano (hmos) e a um método para a fabricação do dito sistema. o sistema de composições nutricionais adaptadas à idade compreende ao menos duas composições nutricionais para lactentes de uma determinada idade, que diferem uma da outra na quantidade de hmos presente nas mesmas. o sistema está especificamente adaptado às necessidades nutricionais em evolução de lactentes desde o nascimento deles até o término do período de amamentação.
BR112017003920A 2014-09-25 2015-09-24 sistema de fórmulas infantis para lactentes com teores adaptativos de oligossacarídeos de leite humano (hmos) BR112017003920A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14186352 2014-09-25
EP15159584 2015-03-18
PCT/EP2015/071930 WO2016046294A1 (en) 2014-09-25 2015-09-24 INFANT FORMULA SYSTEM WITH ADAPTIVE LEVELS OF HUMAN MILK OLIGOSACCHARIDES (HMOs)

Publications (1)

Publication Number Publication Date
BR112017003920A2 true BR112017003920A2 (pt) 2017-12-12

Family

ID=54238414

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017003920A BR112017003920A2 (pt) 2014-09-25 2015-09-24 sistema de fórmulas infantis para lactentes com teores adaptativos de oligossacarídeos de leite humano (hmos)

Country Status (10)

Country Link
US (1) US10820616B2 (pt)
EP (1) EP3197295B1 (pt)
CN (1) CN106714583A (pt)
AU (2) AU2015323762A1 (pt)
BR (1) BR112017003920A2 (pt)
ES (1) ES2725464T3 (pt)
MX (1) MX2017003441A (pt)
PH (1) PH12017500174A1 (pt)
RU (1) RU2761533C2 (pt)
WO (1) WO2016046294A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106714583A (zh) 2014-09-25 2017-05-24 雀巢产品技术援助有限公司 具有自适应水平的人乳寡糖(hmo)的婴儿配方食品体系
US20180078572A1 (en) * 2015-03-05 2018-03-22 Nestec S.A. Compositions for use in improving stool consistency or frequency in infants or young children
ES2911377T3 (es) * 2016-01-26 2022-05-19 Nestle Sa Composiciones que comprenden oligosacáridos de leche humana para su uso en lactantes o niños pequeños para prevenir o tratar alergias
MX2018008953A (es) * 2016-01-26 2018-09-03 Nestec Sa Composiciones que comprenden 2fl y lnnt para usar en infantes o niños pequeños para prevenir la obesidad en la vida posterior o comorbilidades relacionadas.
WO2017129639A1 (en) * 2016-01-26 2017-08-03 Nestec S.A. Compositions comprising human milk oligosaccharides for use in infants or young children to prevent or treat a health disorder by increasing glp-1 secretion
CN109562117A (zh) * 2016-08-04 2019-04-02 雀巢产品技术援助有限公司 具有2FL和LNnT的营养组合物,用于通过作用于肠道微生物群生态失调来预防和/或治疗非轮状病毒腹泻
US20180103675A1 (en) 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
PL234411B1 (pl) * 2017-01-20 2020-02-28 Milart Pawel Kompozycja żywieniowa do żywienia doustnego i dojelitowego dzieci
WO2018206434A1 (en) * 2017-05-09 2018-11-15 Nestec S.A. Synergistic production of butyrate associated with the complexity of hmos blend for use in infants or young children for health purposes
WO2019038668A1 (en) 2017-08-21 2019-02-28 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
JP7273824B2 (ja) * 2017-12-29 2023-05-15 ソシエテ・デ・プロデュイ・ネスレ・エス・アー セルピン産生
GB2573539A (en) * 2018-05-09 2019-11-13 Mjn Us Holdings Llc Wellbeing supplement for postpartum maternal nutrition
AU2019389456A1 (en) * 2018-11-30 2021-05-13 Societe Des Produits Nestle S.A. Infant nutritional composition for use in the enhancement of pancreatic maturation and insulin biosynthesis
US11166862B2 (en) 2018-12-06 2021-11-09 General Electric Company System and method for a thermoregulated environment
CN113163833A (zh) * 2018-12-21 2021-07-23 雀巢产品有限公司 包含6′sl和lnt的组合以改善胃肠屏障功能的营养组合物
ES1240969Y (es) * 2019-09-18 2020-07-30 Jennewein Biotechnologie Gmbh Composiciones de cereales que contienen oligosacaridos de la leche humana
MX2022006411A (es) * 2019-12-09 2022-07-01 Nestle Sa Composiciones que comprenden oligosacaridos de la leche humana para uso en un sujeto para apoyar el desarrollo del lenguaje.
GB2590375B (en) * 2019-12-11 2024-05-08 Mjn Us Holdings Llc Staged nutritional compositions containing human milk oligosaccharides and uses thereof
CN114760861A (zh) * 2019-12-30 2022-07-15 雀巢产品有限公司 婴儿配方食品
KR102241938B1 (ko) * 2020-09-14 2021-04-20 (주)에이피테크놀로지 2'-푸코실락토오스를 포함하는 뇌심혈관 질환 개선용 식품 조성물
EP4186512A4 (en) 2020-09-14 2024-08-14 Advanced Protein Tech Corp FOOD COMPOSITION FOR THE ALLEVIATION OR TREATMENT OF CARDIOCEREBROVASCULAR DISEASE AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF CARDIOCEREBROVASCULAR DISEASE CONTAINING 2'-FUCOSYLLACTOSE
US20240032581A1 (en) * 2020-12-18 2024-02-01 Societe Des Produits Nestle S.A. Synthetic nutritional compositions tailored for chinese infants
MX2023008202A (es) * 2021-01-29 2023-07-18 Nestle Sa Mezcla de hmo y bifidobacteria.
WO2022253980A1 (en) 2021-06-02 2022-12-08 N.V. Nutricia Lactation stage specific infant nutrition
CA3223920A1 (en) 2021-06-29 2023-01-05 The Broad Institute, Inc. Bifidobacterium longum transitional microorganisms, compositions and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
US7867541B2 (en) 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
EP2272381B1 (en) 2007-11-26 2018-12-26 Nestec S.A. Age-tailored nutrition system for infants
EP2143341A1 (en) * 2008-07-08 2010-01-13 Nestec S.A. Nutritional Composition Containing Oligosaccharide Mixture
EP2452574A1 (en) 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for young infants
US20120219526A1 (en) * 2009-10-29 2012-08-30 Nestec S.A. Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof
CN102858191A (zh) 2010-04-27 2013-01-02 N.V.努特里奇亚 6’-唾液酸化乳糖在婴儿和幼儿营养物中的用途
SG10201603856PA (en) 2010-12-31 2016-07-28 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
WO2012092158A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
EP2522232A1 (en) * 2011-05-13 2012-11-14 Nestec S.A. Nutritional products comprising human milk oligosaccharides and methods for manufacture thereof
NL2007268C2 (en) 2011-08-16 2013-02-19 Friesland Brands Bv Nutritional compositions comprising human milk oligosaccharides and uses thereof.
WO2013032674A1 (en) * 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
EP2656862A1 (en) * 2012-04-24 2013-10-30 The Procter & Gamble Company Substrate comprising one or more human milk oligosaccharides and disposable absorbent article comprising the substrate
EP3936134A1 (en) * 2012-11-02 2022-01-12 N.V. Nutricia Synbiotics combination for brain improvement
EP2880993A1 (en) 2013-12-04 2015-06-10 Abbott Laboratories Method of achieving memory and learning improvement by the administration of sialic acid
CN106714583A (zh) 2014-09-25 2017-05-24 雀巢产品技术援助有限公司 具有自适应水平的人乳寡糖(hmo)的婴儿配方食品体系

Also Published As

Publication number Publication date
RU2017113997A3 (pt) 2019-04-29
US20170295838A1 (en) 2017-10-19
ES2725464T3 (es) 2019-09-24
EP3197295A1 (en) 2017-08-02
WO2016046294A1 (en) 2016-03-31
RU2017113997A (ru) 2018-10-25
MX2017003441A (es) 2017-06-20
PH12017500174A1 (en) 2017-07-10
EP3197295B1 (en) 2019-03-06
AU2015323762A1 (en) 2017-02-16
US10820616B2 (en) 2020-11-03
CN106714583A (zh) 2017-05-24
RU2761533C2 (ru) 2021-12-09
AU2020201932A1 (en) 2020-04-09

Similar Documents

Publication Publication Date Title
BR112017003920A2 (pt) sistema de fórmulas infantis para lactentes com teores adaptativos de oligossacarídeos de leite humano (hmos)
BR112017002627A2 (pt) prebióticos para reduzir o risco de obesidade no futuro
BR112015023484A2 (pt) composição de carboidrato, produto e processso para preparar uma composição de carboidrato
BR112017025388A2 (pt) plantas cannabis tendo expressão modificada de thca sintase
BR112018013538A2 (pt) composições compreendendo 2fl e lnnt para uso em bebês ou crianças pequenas para evitar a obesidade, ou comorbidades relacionadas, em fases posteriores da vida
BR112017003948A2 (pt) composição
BR112017010837A2 (pt) padronizações e dispositivos médicos para a preparação de plasma rico em plaqueta (prp) ou concentrado de medula óssea (bmc) sozinho ou em combinação com ácido hialurônico
MX2023005755A (es) Composicion que comprende sialillactosa para usar para mejorar las aptitudes de aprendizaje y la funcion de memoria.
BR112019006341A2 (pt) produtos de nutrição pediátrica personalizados que compreendem oligossacarídeos de leite humano
PH12019550208A1 (en) Hmos blends for use in infants or young children for health purposes
BR112016012245A8 (pt) composição de confeitos congelados com quantidade reduzida de açúcar
AR100123A1 (es) Composición nutricional pediátrica con oligosacáridos de leche humana, prebióticos y probióticos
BR112017007375A2 (pt) composição compreendendo oligossa¬carídeos fut2 dependentes e lacto-n-neotetraose para uso na promoção do desenvolvimento e da cognição cerebral
BR112016006649A2 (pt) biscoito macio com glicose de liberação lenta
BR112013024199A2 (pt) métodos para melhorar a saúde óssea em bebês usando prebióticos
BR112017007261A2 (pt) composições nutricionais compreendendo sn-1 (3) monoacilgliceróis para uso no tratamento da má absorção ou má digestão em bebês ou crianças pequenas
BR112016021648A2 (pt) novos compostos
AR102085A1 (es) Composición nutricional para el entorno gastrointestinal para la provisión de un perfil metabólico y microbioma mejorados
BR112018008040A2 (pt) composição nutricional compreendendo um hidrolisado de caseína, bem como um butirato dietético e/ou um composto para estimular a formação de butirato endógeno
BR112012023328A2 (pt) composições nutricionais
BR112018011793A2 (pt) composições nutricionais e fórmulas para bebês para promover mielinização no cérebro
BR112013006965A2 (pt) combinação de substitutos de gordura para a substituição total ou parcial de gordura em produtos alimentares, e um produto alimentar compreendendo a mesma
BR112015006740A2 (pt) modulação da função imunológica por lactoferrina bovina dietética
BR112012020064A2 (pt) produto de leite e método de produzir o referido produto
BR112017015924A2 (pt) promotor de rendimento para aumentar a sacarose e derivados de sacarose em plantas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]